Toxicity of copper salts is dependent on solubility profile and cell type tested

Toxicology in Vitro

Volumn 27, Issue 2, 2013, Pages 844-851

  Shaligram, Sonali ^a   Campbell, Arezoo ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Cell viability; Copper; Glial cells; Neuronal cells; Oxidative stress

Indexed keywords

COPPER; COPPER OXIDE; COPPER SULFATE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE;

ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; GLIOBLASTOMA; HUMAN; HUMAN CELL; NEUROBLASTOMA; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PARTICLE SIZE; SOLUBILITY;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COPPER; HUMANS; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SOLUBILITY;

EID: 84872730123     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.12.026     Document Type: Article

References (38)

1. Alcaraz-Zubeldia M., Montes S., Rion C. Participation of manganese-superoxide dismutase in the neuroprotection exerted by copper sulfate against 1-methyl 4-phenylpyridinium neurotoxicity. Brain Res. Bull. 2001, 55:277-279.
2. Armstrong C.W., Moore L.W., Hackler R.L., Miller G.B., Stroube R.B. An outbreak of metal fume fever. Diagnostic use of urinary copper and zinc determinations. J. Occup. Med. 1983, 25:886-888.
3. 3) to Escherichia coli, Bacillus subtilis, and Streptococcus aureus. Sci. Tot. Environ. 2011, 409:1603-1608.
4. Barceloux D.G. Copper. J. Toxicol. Clin. Toxicol. 1999, 37:217-230.
5. Bayer T.A., Schafer S., Simons A., Kemmling A., Kamer T., Tepest R., Eckert A., Schussel K., Eikenberg O., Sturchler-pierrat C., Abramowski D., Staufenbiel M., Multhaup G. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. PNAS 2003, 100:14187-14192.
6. Becaria A., Bondy S.C., Campbell A. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease. JAD 2003, 5:31-38.
7. Becaria A., Lahiri D.K., Bondy S.C., Chen D., Hamadeh A., Li H., Taylor R., Campbell A. Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. J. Neuroimmunol. 2006, 176:16-23.
8. Bush A.I., Masters C.L., Tanzi R.E. Copper, β-amyloid, and Alzheimer's disease: tapping a sensitive connection. PNAS 2003, 100:11193-11194.
9. Campbell A. The role of aluminum and copper on neuroinflammation and Alzheimer's disease. JAD 2006, 10:165-172.
10. Campbell A., Sayre L.M., Smith M.A., Bondy S.C., Perry G. Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res. Bull. 2001, 55:125-132.
11. J mouse is a better model of hepatic than brain Cu toxicity. Int. J. Clin. Exp. Med. 2008, 1:76-88.
12. Deibel M.A., Ehmann W.D., Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurological Sci. 1996, 143:137-142.
13. Desai V., Kaler S.G. Role of copper in human neurological disorders. Am. J. Clin. Nutr. 2008, 88:855S-858S.
14. Fahmy B., Cormier S.A. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol. In Vitro 2009, 23:1365-1371.
15. Fortunato E., Barguinha P., Martins R. Oxide semiconductor thin-film transistors: a review of recent advances. Adv. Mater. 2012, 24:2945-2986.
16. Gaetke L.M., Chow C.K. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003, 189:147-163.
17. Karlsson H.L., Cronholm P., Gustafsson J., Moller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21:1726-1732.
18. Kitzberger R., Madl C., Ferenci P. Wilson Disease. Metab. Brain Dis. 2005, 20:295-302.
19. Linder M.C., Hazegh-Azam M. Copper biochemistry and molecular biology. Am. J. Clin. Nutr. 1996, 63:797S-811S.
20. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998, 158:47-52.
21. Michaud J.P., Angela K.G. Sub-lethal effects of a copper sulfate fungicide on development and reproduction in three coccinellid species. J. Insect Sci. 2003, 3:16.
22. Miller L.M., Wang Q., Telivala T.P., Smith R.J., Lanzirotti A., Miklossy J. Synchroton-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer's disease. J. Struct. Biol. 2005, 152:204-211.
23. Molina J.A., Jiménez-Jiménez F.J., Aguilar M.V., Meseguer I., Mateos-Vega C.J., González-Muñoz M.J., de Bustos F., Porta J., Ortí-Pareja M., Zurdo M., Barrios E., Martínez-Para M.C. Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J. Neural. Trans. 2003, 105(4-5):479-488.
24. Perry G., Taddeo M.A., Peterson R.B., Castellani R.J., Harris P.L.R., Siedlak S.L., Cash A.D., Liu Q., Nunomura A., Atwood C.S., Smith M.A. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer's disease. Biometals 2003, 16:77-81.
25. Pope S.A.S., Milton R., Heales S.J.R. Astrocytes protect against copper-catalysed loss of extracellular glutathione. Neurochem. Res. 2008, 33:1410-1418.
26. Qian Y., Zheng Y., Abraham L., Ramos K.S., Tiffany-Castiglioni E. Differential profiles of copper-induced ROS generation in human neuroblastoma and astrocytoma cells. Mol. Brain Res. 2005, 134:323-332.
27. Sayre L.M., Perry G., Smith M.A. Redox metals and neurodegenerative disease. Curr. Opinion Chem. Biol. 1999, 3:220-225.
28. Sheline C.T., Choi E.H., Kim-Han J.S., Dugan L.L., Choi D.W. Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann. Neurol. 2002, 52:195-204.
29. Sparks D.L., Schreurs B.G. Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. PNAS 2003, 100:11065-11069.
30. Spinsi E., Valerii M.C., Manerba M., Strillacci A., Polazzi E., Mattia T., Griffoni C., Tomasi V. Effect of copper on extracellular levels of key proinflammatory molecules in hypothalamic GN11 and primary neurons. Neurotoxicology 2009, 30:605-612.
31. Squitti R., Lupoi D., Pasqualetti P., Dal Forno G., Vernieri F., Chiovenda P., Rossi L., Cortesi M., Cassetta E., Rossini P.M. Elevation of serum copper levels in Alzheimer's disease. Arch. Neurol. 2002, 59:1153-1161.
32. Strecker K., Schneider J.P., Barthel H., Hermann W., Wegner F., Wagner A., Schwarz J., Sabri O., Zimmer C. Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms?. J. Neurol. 2006, 253:1024-1029.
33. Studer A.M., Limbach L.K., Van Duc L., Krumeich F., Athanassiou E.K., Gerber L.C., Moch H., Stark W.J. Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicol. Lett. 2010, 197:169-174.
34. Tapiero H., Townsend D.M., Tew K.D. Trace elements in human physiology and pathology. Copper Biomed. Pharmacother. 2003, 57:386-398.
35. Tiffany-Castiglioni E., Guerri C., Aschner M., Matsushima G.K., O'Callaghan J.P., Streit W.J. Roles of glia in developmental neurotoxicity: session VI summary and research needs. Neurotoxicology 2001, 22:567-573.
36. Wang X.F., Cynader M.S. Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J. Neurosci. 2001, 21:3322-3331.
37. Watt N.T., Hooper N.M. The response of neurones and glial cells to elevated copper. Brain Res. Bull. 2001, 55:219-224.
38. White A.R., Cappai R. Neurotoxicity from glutathione depletion is dependent on extracellular trace copper. J. Neurosci. Res. 2003, 71:889-897.